NEW YORK (GenomeWeb News) – Genetic engineering company Intrexon has raised $25 million in equity financing, according to a form filed this week with the SEC.

Intrexon, formerly known as Genomatix, is based in Blacksburg, Va., and uses modular DNA control systems to enhance capabilities, improve safety, and lower cost in human therapeutics, protein production, industrial enzymes, and agriculture, according to the company's website.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.